EWG
Twitter
Instagram
CDC finds weed killer tied to cancer in over 80 pct of US urine samples
In fresh evidence of the pervasive nature of pesticides, more than 80 percent of urine samples drawn from children and adults participating in a US health study contained a weedkilling chemical linked to cancer and other health problems.
The June 30 report by a unit of the Centers for Disease Control and Prevention (CDC) found that out of 2,310 urine samples collected, 1,885 were laced with detectable traces of glyphosate, the active ingredient in herbicides sold around the world, including the widely used Roundup brand.
Guest column: The Roundup reckoning: Farmworkers win key glyphosate decision
Earlier this month, a court decision about a chemical called glyphosate garnered headlines in newspapers across the country. And rightly so: glyphosate is the active ingredient in Monsanto’s Roundup weedkiller.
Bayer wins latest Roundup cancer trial; tied 3-to-3 with plaintiffs for court wins
A Kansas City, Mo., jury on Thursday dismissed claims by a man who blamed his cancer on exposure to Monsanto’s Roundup herbicide, agreeing with the company that the weed killer was not the source of the man’s disease.
The conclusion of the month-long trial gives Monsanto owner Bayer three courtroom wins in a row and brings the nationwide litigation battle to a 3-to-3 tie: the first three trial wins went to the plaintiffs’ side and the last three to the defense.
“The jury’s verdict in favor of the company brings this trial to a successful conclusion and is consistent with the evidence in this case that Roundup does not cause cancer…” Bayer said in a statement.
Monsanto’s former CEO testifies in Roundup trial, points to EPA safety findings
Former Monsanto chief Hugh Grant spent several hours on the witness stand on Tuesday – testifying for the first time in front of a jury at a Roundup trial – telling the court repeatedly that global regulators had found no evidence that the company’s herbicides cause cancer.
Under sharp questioning from the plaintiff’s attorney in the case, Grant answered questions about whether or not Monsanto had a duty to warn consumers of a cancer risk by saying there was no such established risk.
“The product had been examined and studied almost continuously for 40 years around the world and had never been deemed to be a carcinogen,” he said. “It’s a circumstance that never occurred. There was never, never a need to communicate such a hypothetical.”
During his 37 years at the company, Grant said: “The reality is that based on regulatory examination almost constantly during that entire period the product was never found to cause cancer.”
Ag groups push Biden to withdraw Justice Dept. finding on Roundup litigation
Two weeks after a top Justice Department official advised the U.S. Supreme Court there was “no sound reason” for the high court to review a loss by Monsanto owner Bayer AG in nationwide Roundup cancer litigation, a coalition of large agricultural groups is demanding that President Joe Biden withdraw the opinion.
Bayer, which bought Monsanto in 2018, has looked to the high court as its last, and best, hope for putting an end to the ongoing litigation. Bayer has asked the justices to take up the case, which centers on allegations that Monsanto’s glyphosate-based herbicides such as Roundup cause non-Hodgkin lymphoma (NHL.)
Another legal blow to Bayer in Roundup litigation
The U.S. Solicitor General on Tuesday dealt a blow to Monsanto owner Bayer AG, advising the U.S. Supreme Court that it should deny the company’s request for a review of a key Roundup cancer trial loss.
Bayer has seen the Supreme Court as its last and best hope for putting a stop to the flood of lawsuits filed by tens of thousands of people claiming exposure to Roundup weed killing products caused them to develop non-Hodgkin lymphoma (NHL).
The brief from Solicitor General Elizabeth Prelogar states that “There is no sound reason for the Court to grant review…”
Monsanto on trial again – Missouri Roundup case begins
Nearly four years after the first-ever trial over allegations that exposure to Roundup herbicide causes cancer a new trial was underway on Tuesday, pitting a 34-year-old man suffering from non-Hodgkin lymphoma (NHL) against Monsanto owner Bayer AG.
Allan Shelton, a lifelong resident of Kansas City, Mo., was diagnosed with NHL in May 2016, a little more than a year after international cancer scientists affiliated with the World Health Organization classified the active ingredient in Roundup, a chemical called glyphosate, as a probable human carcinogen.
Former Monsanto CEO could have to testify at upcoming Roundup trial
Former Monsanto CEO Hugh Grant lost his appeal to escape testifying at an upcoming trial over claims that the company’s Roundup herbicide causes cancer.
The Missouri Court of Appeals Western District on Friday denied Grant’s petition that sought to quash a subpoena compelling Grant to testify in person in the case of Allan Shelton v Monsanto. The trial of the civil suit is set to begin May 2 in Kansas City, Missouri.
California regulators changing language on glyphosate and cancer risk
The California Office of Environmental Health Hazard Assessment (OEHHA) is proposing changes to its messaging to consumers regarding the cancer risk associated with products made with the weed killing chemical glyphosate.
The language shift is subtle, but is significant for multiple reasons, including the potential for it to impact Monsanto’s efforts to appeal trial losses to the U.S. Supreme Court.
Former Monsanto CEO files for protective order in Roundup case
Former Monsanto Co. Chairman and CEO Hugh Grant is appealing a judge’s order that would allow lawyers for a cancer patient to question him on the stand in a trial scheduled to start next month in Kansas City.
Lawyers for the former Monsanto executive filed a flurry of documents with the Missouri Court of Appeals Western District on Friday seeking to quash a subpoena compelling Grant to testify in person in the case of Allan Shelton v Monsanto.